SWP
IONS icon

Significant Wealth Partners’s Ionis Pharmaceuticals IONS Stock Holding History

Significant Wealth Partners’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$524K Sell
6,613
-51
-0.8% -$3.84K 0.57% 51
2026
Q1 		$500K Sell
6,664
-100
-1% -$7.89K 0.62% 45
2025
Q4 		$535K Sell
6,764
-8,203
-55% -$618K 0.6% 18
2025
Q3 		$979K Sell
14,967
-537
-3% -$26.2K 0.48% 15
2025
Q2 		$613K Buy
15,504
+1,899
+14% +$62.1K 0.3% 27
2025
Q1 		$410K Buy
13,605
+2,700
+25% +$88.4K 0.21% 42
2024
Q4 		$381K Buy
+10,905
New +$408K 0.2% 39

Other funds holding IONS

Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
DC
Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
WP
Westmount Partners Los Angeles, California $457M AUM 31.05% 1-Year Est. Return
PL
Plancorp LLC Saint Louis, Missouri $4.1B AUM 25.19% 1-Year Est. Return
PR
PSP Research Newtown Square, Pennsylvania $188M AUM
TE
Tema ETFs New York $3.09B AUM 72.72% 1-Year Est. Return
MFT
Moisand Fitzgerald Tamayo Orlando, Florida $1.02B AUM 21.26% 1-Year Est. Return

Significant Wealth Partners's IONS Position: Q2 2026 in Review

Significant Wealth Partners reduced its Ionis Pharmaceuticals (IONS) stake by 0.77% in Q2 2026, selling an estimated $3.84K and leaving 6,613 shares worth $524K. The position accounts for 0.57% of the portfolio, ranked #51.

Significant Wealth Partners first reported a position in IONS in Q4 2024 and has held it in 7 quarters since. The position peaked at $979K in Q3 2025. 41 funds tracked by Wall St. Rank hold IONS as of Q2 2026.

  • Significant Wealth Partners held 6,613 shares of Ionis Pharmaceuticals worth $524K as of Q2 2026.
  • Significant Wealth Partners sold 51 Ionis Pharmaceuticals shares in Q2 2026, an estimated $3.84K.
  • Ionis Pharmaceuticals made up 0.57% of Significant Wealth Partners's portfolio in Q2 2026, its #51 holding.
  • Significant Wealth Partners first reported a position in Ionis Pharmaceuticals in Q4 2024 and has held it in 7 quarters since.
  • Significant Wealth Partners's Ionis Pharmaceuticals position peaked at $979K in Q3 2025.
  • 41 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q2 2026.

Based on Significant Wealth Partners's 13F filing for Q2 2026, filed 14 Jul 2026.